000			03996nam a22004095i 4500
001			84670
003			ES-MaUEC
005			20230207040435.0
007			cr nn 008mamaa
008			150826s2016 gw a fs 001 0 eng d
020			_a9783319199115
040			_aES-MaUEC
050		4	_aRC392 _b2016 EB
082	0	4	_a616
245	0	0	_aPharmacological Management of Headaches _cedited by Dimos D Mitsikostas, Koen Paemeleire
260			_aCham _bSpringer International Publishing _c2016
300			_a1 recurso en línea (X, 250 p.) _b10 ilustraciones, 4 ilustraciones en color
336			_aTexto (visual) _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
490	1		_aHeadache _x2197-652X
505	0		_a1 Headache classification -- 2 Epidemiology of headache disorders -- 3 General principles of pharmacotherapy for headache disorders -- 4 Placebo and nocebo effects -- 5 Review of existing guidelines -- 6 Acute migraine treatment -- 7 Preventive (episodic) migraine treatment -- 8 Drug treatment for chronic migraine -- 9 Drug treatment for episodic and chronic tension-type headache (TTH) -- 10 Cluster headache: acute and transitional treatment -- 11 Cluster headache: preventive treatment -- 12 Pharmacotherapy for other primary headache disorders -- 13 Pharmacotherapy for primary headache disorders in children -- 14 Pharmacological strategies in the prevention of migraine in children -- 15 Pharmacotherapy for primary headache disorders during pregnancy and lactation -- 16 Pharmacotherapy for primary headache disorders in the elderly -- 17 Acute and chronic posttraumatic headache -- 18 Headache attributed to low and increased CSF pressure -- 19 Medication-overuse headache -- 20 Painful cranial neuropathies -- 21 Dental and Musculoskeletal Pain -- 22 Post-traumatic neuropathies and Burning mouth syndrome.
520	3		_aIn this book, headache experts summarize all the currently available therapies for primary headaches and most importantly, describe the {u2018}tricks{u2019} that can ensure the success of headache pharmacotherapy. Prevention and acute treatment of migraine and cluster headache receive particular attention and individual chapters are devoted to the treatment of primary headaches in special groups, i.e. children, pregnant women and the elderly. Further chapters focus on selected secondary headache disorders and cranial neuralgias for which pharmacotherapy is available. The book is designed to meet the daily practice needs of general physicians, general neurologists, neurologists in training and medical students. Headache remains a leading reason for people to seek medical consultation, and migraine and other primary headache disorders are classified by the WHO as among the most disabling medical conditions in the general population, often affecting individuals during their most productive years. Unfortunately, under treatment and mismanagement are the fate of many headache patients and this book provides a sound basis for optimizing treatment.
710	2		_aSpringerLink (Online service) _0Local _9106996
942			_2lcc _cLE
650		7	_aCefalalgia _xTratamiento _0comprobar BNE19901099245 _2embne _9170617
650		7	_aCabeza _xEnfermedades _0comprobar BNE19913273588 _2embne _9187238
700	1		_aMitsikostas, Dimos D. _eeditor literario _997019 _0Local
700	1		_aPaemeleire, Koen _eeditor literario _997020 _0Local
830		0	_aHeadache _x2197-652X _9125030 _0Local
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-19911-5 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901			_ai9783319199115
907			_a.b12939481 _b10-10-17 _c21-11-16
988			_aSpringer_Medicine_2016
998			_am _a_alco _a_vill _b27-06-17 _cm _dz _ea _feng _ggw _h0
945			_aRC392 .P43 2016 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11583976 _z06-04-17
999			_c84670 _d84670 _x1